Eisai Co., Ltd. (TYO:4523)
4,605.00
+35.00 (0.77%)
Apr 28, 2026, 3:30 PM JST
Eisai Employees
Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.
Employees
10,917
Change (1Y)
-150
Growth (1Y)
-1.36%
Revenue / Employee
74.03M JPY
Profits / Employee
3.92M JPY
Market Cap
1,298.11B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sumitomo Pharma | 3,832 |
| Shionogi & | 4,955 |
| Hisamitsu Pharmaceutical Co. | 2,799 |
| Nippon Shinyaku | 2,243 |
| Toho Holdings | 7,609 |
| Tsumura & Co. | 4,272 |
| Sawai Group Holdings | 3,310 |
| Towa Pharmaceutical | 4,788 |
Eisai News
- 7 days ago - Why Is Merck Stock Falling Tuesday? - Benzinga
- 7 days ago - Merck (MRK) and Eisai's Keytruda Trial Fails to Meet Goals in Kidney Cancer Study - GuruFocus
- 7 days ago - Merck-Eisai's combination cancer therapy fails to meet main goals of late-stage study - Reuters
- 10 days ago - These Alzheimer's drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated. - Market Watch
- 19 days ago - Eisai to Present the Latest Data on Real-World Treatment with Lecanemab and Supporting a Standardized Framework for Treating Early Alzheimer's Disease at the 78th American Academy of Neurology's Annual Meeting - PRNewsWire
- 4 weeks ago - Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency - PRNewsWire
- 2 months ago - Eisai Earnings Call Transcript: Q3 2026 - Transcripts
- 2 months ago - Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan - PRNewsWire